Most cited papers in Pharmaceutical industry and healthcare
What are the most cited papers in Pharmaceutical industry and healthcare?
The most cited paper in Pharmaceutical industry and healthcare is "Opportunities and responsibilities in pharmaceutical care" (Charles D. Hepler, Linda M. Strand, 1990), with 2,920 citations. Next come "Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy" (2,471) and "Pharmaceutical industry sponsorship and research outcome and quality: systematic review" (2,181).
Showing 50 of 99 papers. Every paper with more than 448 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Opportunities and responsibilities in pharmaceutical care Charles D. Hepler, Linda M. Strand · American Journal of Health-System Pharmacy | Mar 1990 | 2,920 |
| 2 | Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy Erick H. Turner, Annette M. Matthews, Eftihia Linardatos et al. · New England Journal of Medicine | 16 Jan 2008 | 2,471 |
| 3 | Pharmaceutical industry sponsorship and research outcome and quality: systematic review Joel Lexchin, Lisa A Bero, Benjamin Djulbegovic et al. · BMJ | 29 May 2003 | 2,181 |
| 4 | Ethical authorship and publishing Andrew J.S. Coats · International Journal of Cardiology | 29 Nov 2008 | 2,143 |
| 5 | How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data Daniele Fanelli · PLoS ONE | 28 May 2009 | 1,972 |
| 6 | Patient adherence to treatment: three decades of research. A comprehensive review Etienne Vermeire, Hilary Hearnshaw, Paul Van Royen et al. · Journal of Clinical Pharmacy and Therapeutics | Oct 2001 | 1,862 |
| 7 | Scope and Impact of Financial Conflicts of Interest in Biomedical Research Justin E. Bekelman, Yan Hai Li, Cary Philip Gross · JAMA | 22 Jan 2003 | 1,837 |
| 8 | Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results Pilar Suñé, Josep María Suñé, J. Bruno Montoro · PLoS ONE | 30 Jan 2013 | 1,713 |
| 9 | Industry sponsorship and research outcome Andreas Lundh, Joel Lexchin, Barbara J. Mintzes et al. · Cochrane Database of Systematic Reviews | 16 Feb 2017 | 1,617 |
| 10 | Sociobehavioral Determinants of Compliance with Health and Medical Care Recommendations Marshall H. Becker, Lois A. Maiman · Medical Care | 1975 | 1,599 |
| 11 | Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine Adele E. Clarke, Laura Mamo, Jennifer R. Fishman et al. · American Sociological Review | Apr 2003 | 1,555 |
| 12 | Contradicted and Initially Stronger Effects in Highly Cited Clinical Research John P. A. Ioannidis · JAMA | 12 Jul 2005 | 1,480 |
| 13 | Physicians and the Pharmaceutical Industry Ashley D. Wazana · JAMA | 19 Jan 2000 | 1,423 |
| 14 | Distrust, Race, and Research Giselle M. Corbie-Smith, Stephen B. Thomas, Diane Marie M. St. George · Archives of Internal Medicine | 25 Nov 2002 | 1,092 |
| 15 | Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making Stephen B. Soumerai · JAMA | 26 Jan 1990 | 1,059 |
| 16 | The Shifting Engines of Medicalization Peter Conrad · Journal of Health and Social Behavior | Mar 2005 | 1,050 |
| 17 | Ethics in the authorship and publishing of scientific articles Louise Gabrielle Shewan, Andrew J.S. Coats · International Journal of Cardiology | 18 Aug 2010 | 1,012 |
| 18 | Timing of New Black Box Warnings and Withdrawals for Prescription Medications Karen E. Lasser · JAMA | May 2002 | 1,011 |
| 19 | What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies Alison M. McDonald, Rochelle Knight, Marion Campbell et al. · Trials | 7 Apr 2006 | 975 |
| 20 | Perceived fairness of employee drug testing as a predictor of employee attitudes and job performance. Mary A. Konovsky, Russell Cropanzano · Journal of Applied Psychology | 1991 | 963 |
| 21 | Full publication of results initially presented in abstracts Roberta W. Scherer, PATRICIA W. LANGENBERG, Erik B von Elm · Cochrane Database of Systematic Reviews | 3 Apr 2007 | 954 |
| 22 | Universities and tobacco money Joanna E Cohen · BMJ | 7 Jul 2001 | 944 |
| 23 | Epidemiology and Reporting Characteristics of Systematic Reviews David Moher, Jennifer Tetzlaff, Andrea C. Tricco et al. · PLoS Medicine | 22 Mar 2007 | 909 |
| 24 | Publication bias in clinical trials due to statistical significance or direction of trial results Sally Hopewell, Kirsty Loudon, Mike J Clarke et al. · Cochrane Database of Systematic Reviews | 21 Jan 2009 | 904 |
| 25 | Resisting medicines: a synthesis of qualitative studies of medicine taking Pandora Pound, Nicky Britten, Myfanwy Morgan et al. · Social Science & Medicine | 29 Jan 2005 | 883 |
| 26 | Understanding Financial Conflicts of Interest Dennis Frank Thompson · New England Journal of Medicine | 19 Aug 1993 | 863 |
| 27 | Improving Drug-Therapy Decisions through Educational Outreach Jerry Avorn, Stephen B. Soumerai · New England Journal of Medicine | 16 Jun 1983 | 861 |
| 28 | Office of National Drug Control Policy Bertha Kalifon Madras · Annals of the New York Academy of Sciences | 8 Jan 2010 | 859 |
| 29 | Publication bias: evidence of delayed publication in a cohort study of clinical research projects Jerome M Stern, Robert John Simes · BMJ | 13 Sep 1997 | 837 |
| 30 | Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data Daniele Fanelli · PLoS ONE | 21 Apr 2010 | 829 |
| 31 | The meaning of medications: Another look at compliance Peter Conrad · Social Science & Medicine | 1985 | 823 |
| 32 | Contested Boundaries in Policy-Relevant Science Sheila Jasanoff · Social Studies of Science | May 1987 | 818 |
| 33 | Online Social Networking by Patients with Diabetes: A Qualitative Evaluation of Communication with Facebook Jeremy A. Greene, Niteesh K. Choudhry, Elaine Kilabuk et al. · Journal of General Internal Medicine | 13 Oct 2010 | 801 |
| 34 | Association of Funding and Conclusions in Randomized Drug Trials Bodil E Als-Nielsen, Wendong Chen, Christian Nyfeldt Gluud et al. · JAMA | 19 Aug 2003 | 749 |
| 35 | The burden of skin diseases: 2004 David R. Bickers, Henry W. Lim, David J Margolis et al. · Journal of the American Academy of Dermatology | 13 Aug 2006 | 743 |
| 36 | Off-label Prescribing Among Office-Based Physicians David Radley, Stan N. Finkelstein, Randall Scott Stafford · Archives of Internal Medicine | 8 May 2006 | 715 |
| 37 | Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. Troyen A. Brennan, David J. Rothman, Linda L. Blank et al. · PubMed | 25 Jan 2006 | 704 |
| 38 | CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration Sally Hopewell, Mike J Clarke, David Moher et al. · PLoS Medicine | 16 Jan 2008 | 689 |
| 39 | Effectiveness of Celebrity Endorsers Charles K. Atkin, Martin Paul Block · Journal of Advertising Research | Feb 1983 | 660 |
| 40 | Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry Niteesh K. Choudhry · JAMA | 6 Feb 2002 | 652 |
| 41 | Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications Hans Melander, Jane Ahlqvist-Rastad, Gertie Meijer et al. · BMJ | 29 May 2003 | 644 |
| 42 | Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa Lucy Turner, Larissa Shamseer, Douglas G. Altman et al. · Systematic Reviews | 29 Nov 2012 | 643 |
| 43 | The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest Daylian M. Cain, George F. Loewenstein, Don A. Moore · The Journal of Legal Studies | 2005 | 641 |
| 44 | Building customer trust in mobile commerce Keng Leng Siau, Zixing Shen · Communications of the ACM | Apr 2003 | 641 |
| 45 | The Intention-to-Treat Principle Michelle A. Detry, Roger Lewis · JAMA | 2 Jul 2014 | 640 |
| 46 | Conflict of Interest in the Debate over Calcium-Channel Antagonists Henry T. Stelfox, Grace Chua, Keith O’Rourke et al. · New England Journal of Medicine | 8 Jan 1998 | 621 |
| 47 | Health Care Leonard L. Berry, Neeli M. Bendapudi · Journal of Service Research | 22 Oct 2007 | 612 |
| 48 | Medical Nemesis: The Expropriation of Health Ralph S. Crawshaw · American Journal of Psychiatry | Nov 1976 | 604 |
| 49 | Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology | 15 Mar 2001 | 603 |
| 50 | Failing the Public Health — Rofecoxib, Merck, and the FDA Eric J. Topol · New England Journal of Medicine | 7 Oct 2004 | 602 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.